The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 9.21

Hodgkin Lymphoma

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2017
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to 5 >5 to 10 >10 to 15 >15 to 20 >20 to 25 <=25b >25d
All Races Both Sexes 37,871 34,834 31,045 26,309 22,612 152,671 62,860 215,531
Males 21,103 18,693 15,900 13,296 11,208 80,200 30,566 110,766
Females 16,768 16,140 15,145 13,013 11,404 72,471 32,294 104,765
White Both Sexes 30,738 28,984 26,160 22,837 19,902 128,619 59,871 188,491
Males 17,198 15,626 13,547 11,517 9,940 67,828 30,377 98,206
Females 13,540 13,358 12,613 11,319 9,961 60,791 29,494 90,285
Black Both Sexes 5,116 4,343 3,700 2,695 2,188 18,042 5,210 23,252
Males 2,779 2,296 1,722 1,327 1,040 9,164 3,405 12,569
Females 2,337 2,047 1,978 1,368 1,148 8,878 1,806 10,683
Asian/
Pacific
Islander		 Both Sexes 1,133 963 766 466 286 3,614 + +
Males 615 485 373 256 103 1,831 + +
Females 518 478 392 211 183 1,782 + +
Hispanic Both Sexes 4,969 4,134 3,161 2,590 1,640 16,495 + +
Males 2,761 2,163 1,740 1,422 897 8,982 + +
Females 2,208 1,971 1,421 1,168 744 7,512 + +

Estimated prevalence percent a on January 1, 2017, of the SEER population diagnosed in the previous 25 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.0471 0.0006 0.0101 0.0423 0.0733 0.0830 0.0674 0.0535 0.0491 0.0396 0.0467
Males 0.0502 0.0009 0.0114 0.0438 0.0699 0.0854 0.0755 0.0644 0.0598 0.0485 0.0497
Females 0.0441 0.0003 0.0086 0.0406 0.0767 0.0807 0.0596 0.0436 0.0402 0.0341 0.0441
White Both Sexes 0.0508 0.0005 0.0103 0.0460 0.0798 0.0894 0.0711 0.0560 0.0522 0.0426 0.0501
Males 0.0541 0.0007 0.0112 0.0481 0.0751 0.0917 0.0789 0.0668 0.0628 0.0520 0.0528
Females 0.0476 0.0003 0.0093 0.0437 0.0847 0.0871 0.0635 0.0460 0.0432 0.0367 0.0478
Black Both Sexes 0.0396 0.0009 0.0098 0.0339 0.0622 0.0770 0.0651 0.0504 0.0367 0.0233 0.0414
Males 0.0419 0.0018 0.0122 0.0322 0.0615 0.0769 0.0760 0.0629 0.0499 0.0329 0.0447
Females 0.0375 - 0.0073 0.0356 0.0629 0.0771 0.0556 0.0404 0.0274 0.0184 0.0387
Asian/
Pacific
Islander		 Both Sexes 0.0173 0.0005 0.0077 0.0202 0.0291 0.0247 0.0186 0.0163 0.0159 0.0107 0.0165
Males 0.0183 0.0008 0.0106 0.0228 0.0300 0.0231 0.0193 0.0165 0.0226 0.0106 0.0177
Females 0.0164 - 0.0047 0.0175 0.0283 0.0260 0.0179 0.0161 0.0105 0.0108 0.0155
Hispanic Both Sexes 0.0284 0.0005 0.0088 0.0312 0.0461 0.0453 0.0408 0.0444 0.0490 0.0409 0.0315
Males 0.0306 0.0008 0.0097 0.0336 0.0451 0.0485 0.0459 0.0557 0.0573 0.0574 0.0347
Females 0.0261 0.0002 0.0078 0.0287 0.0472 0.0421 0.0357 0.0343 0.0426 0.0306 0.0287

Footnotes:

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2017 US population estimates based on the average of 2016 and 2017 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years.

b Maximum limited-duration prevalence is 25 years for 1992-2017 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing <=25 and >25.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.